Dr Heijden did the presentation about CHDR at the Psychedelic conference,,,

https://www.icpr-conference.com/speakers/katelijne-van-der-heijden

Seems the Defense Authorization bill has support for research using these drugs for PTSD and "wounds of war". TBA?
The Netherlands is also doing research along with Arizona, Texas and Oregon and more.
Come on Chris, present our research, tell us how it went and try to get us involved with this new funding...JMHFO...GLTA...

https://www.youtube.com/shorts/8b50ODFdMEY

AGN presentation to CHDR later this week. Sure hope we can finally see some real interesting news...GLTA...

Neuroplasticity, dendritic spines, 1hr 40mins. He sites many papers, mostly in mouse/rat trials, in this presentation where neuroplasticity is observed, but it seems that the AGN 'microdosing for Stroke' concept is unique.



Yes, the when and where type of data for the clinical trials could be announced soon. Maybe Oregon where it's legal for research?
I've held this long already and will hold through the finish...
...GLTA...

I had found this presentation a long time ago. Finally found it again and it is a great video including neuroplasticity.

Sure great to see this all finally progressing.

“Investigating neuroplasticity in a clinical setting, as a potential new treatment approach for ischemic stroke patients, is a new and promising area of research,” said Christopher J. Moreau CEO of Algernon. “Algernon is a global leader in this important area of research, and we look forward to further advancing the stroke program through our planned Phase 2a DMT Stroke study.”

Phase 2a Stroke Study Design

Subjects with a confirmed diagnosis of ischemic stroke will be randomized in blinded fashion to receive either DMT or placebo. The primary outcome measure of the study will be safety, and information will be gained on measures of efficacy including preservation of brain tissue, motor recovery, depression and numerous biomarkers linked to the pathophysiology of stroke.

The veteran community has discussed TBI and PTSD issues and treatments involving Psycs. This group may also be a area of recruitment for future stroke/TBI research. There are already a few PTSD studies...

...GLTA...

Microdose DMT for TBI too. There are Veterans organizations interested and discussions of are widely supported for 'shroom therapy' of PTSD... Proof of therapeutic benefits for stroke, etc.?.
...GLTA...

16.8M os? 18.8M os = $400k if?
Hope it's for closing the IPF/CC $2M deal.
Psyc / stroke news please.?.
...GLTA,,,

Seems to be lots of talk about PTSD - TBI - in the Veteran communities from well respected folks for the use of shrooms and/or CBD. I think this could encompass the stroke recovery research use of psylocibin that our company is trying to move forward and of course a new/large group of patients in need.
It's not over and this latest possible deal may help finance more AGN work. I hope they are talking to some of the Veteran groups that are interested and active in this...
...GLTA...

Graphite curbs
After choking exports of chipmaking metals gallium and germanium, China is stepping up its efforts to maintain its manufacturing dominance by restricting exports of graphite, a key material used in electric-vehicle batteries. Beijing's move comes just days after Washington unveiled new restrictions on AI chip exports to China.

Dig deeper: Beijing will require special export permits for three grades of graphite starting December 1, the Ministry of Commerce and the General Administration of Customs said. Temporary controls on five less sensitive graphite items used in industries such as steel, metallurgy, and chemicals were dropped. The new curbs are "conducive to ensuring the security and stability of the global supply chain, and conducive to better safeguarding national security and interests," the ministry said. It clarified that it was not targeting any particular country. Top buyers of graphite from China include the U.S., South Korea, Japan, and India.

Bigger picture: The U.S. has been targeting China's access to advanced technologies over national security concerns, with the Biden administration issuing rules in Sept. to regulate U.S. investments in China in semiconductors and microelectronics, quantum information technologies, and AI. Beijing has pushed back by leveraging its dominance over certain materials. To note, China is the world's top graphite producer and exporter. It also refines over 90% of the world's graphite into the anode material used in EV batteries - the largest component by weight in such batteries.

Ivan Lam, senior analyst at Counterpoint Research, does not expect a major impact in the near term, as graphite exports haven't been completely banned. But he said the material's prices will likely increase due to supply and demand imbalances, including Russia - which was once a major graphite supplier. CLSA's Christopher Richter said it would be a "bold" step to cut the world off from graphite, as that would likely bring EVs to a halt everywhere and probably escalate tensions between China, the U.S. and Europe.

https://greenbatteryminerals.com/green-battery-minerals-identifies-numerous-new-pegmatite-outcrops-at-its-jupiter-lithium-project-in-james-bay-quebec/

Nice looking redone Web site.
...GLTA...

AGN needs to publish the CHDR DMT peer review, or/and,
AGN needs to sell their IPF/CC trial results and Ifenprodil rights,
these should get the phase 2 of the Microdose DMT / stroke trial started which is the real possible success story here.
All investors in this speculative stock would be real happy for some good overdue news. Many would then show support with some further investments
...IMHFO...
...GLTA...

News about Volt/GBM on the company web site...

Also "https://finance.yahoo.com/news/mining-investment-event-north-2023-114500598.html"

...GLTA...

Yes! smoki... That is the strong Ifenprodil research data that apparently AGN is now trying to sell (or still to gather a sponsor?) instead of running the 180 patient CT itself.
Thanks for reposting this news so we can all see the strong results and P values AGN saw during that 2a CT, as a "Secondary" side set of data that was originally for COVID/Long COVID.
It would be too expensive to do both the DMT Microdose for Stroke and this follow on for Ifenprodil CC/IPF. I agree with the DMT path and selling the "rights " for the CC/IPF Ifenprodil research to move that one forward, asap,...JMHO...
...GLTA...

Remember that the DMT Phase 1 was to determine "sub psychedelic dose levels". AGN had also paid for specific neuro marker tests that should help prove ' MOU/ proof of concept' for the upcoming Phase 2 CT, which is/has been planned now.
I sure hope that phase 2 data from the Ifenprodil CT will help find a buyer as that data is as strong as any drug's for IPF/CC. This should be enough to finance the next steps for DMT, possible even the whols Phase 2 CT. I bet this is 'of course' the main focus for Mr Monroue.
The peer data from DMT should also be released soon.
As 60% owners of AGN-Neuro we are financing all this and at the least will see proportional benefits, maybe even the dividends you mentioned. JMHO.
...GLTA...

Stroke is like cancer, IMO. There will be plenty of folks willing to try anything to help. Most cancer drugs are $10k a treatment / dose ( Ketruda/Optivo) and some were $70k a dose (Yeravoy).
So basically I see the stroke treatment is doctor supervision costs and the DMT probably will be much less per dose. Certainly a large patient population that needs something.
Sure hope they can sell their/our work and rights from the Ifenprodil Clinical Trials, CC/IPF, to help finance this. Seemed a viable alternative to the other much more expensive drugs with about equal results...
...GLTA...

Looks like the Canadian fires are not anywhere near the GBM properties. Hope to have some summer news
,,,GLTA,,,

Dr jacki Smith gives the final wrap up. Isnt she an advisor for AGN?
Anyway nice to see our drug mentioned with the other big names. Didnt Ifenprodil beat Gabapixen in a murine test by +40%?

Play the whole video, "therapeutic landscape" ( or)16:30+

...GLTA...

https://www.americancoughconference.com/#:~:text=The%20American%20Cough%20Conference%20is%20the%20world%27s%20leading,the%20generous%20support%20of%20our%20sponsors%20and%20exhibitors.

After the 80k of buys someone dropped the pps 5% with a one hundred share buy. I had a hard time getting 5k yesterday @ .1825, as I try to support the pps occasionally. I sure dont understand that the ask was .185 and this 100 shares went @ .17. I dont understand a lot of stuff, LOL...
I hope they expedite the readout of the Stage 1 asap and we see some actual continued interest. Could happen...
...GLTA...

$20 trades to suppress the PPS?

Lithium project this summer.

https://greenbatteryminerals.com/news/

If everything flows right there sould be a decimal point move. Moves?
Algernon may bloom. Break out the Truck.
Good thoughtful timing and successful trial data reviews in well written PR's whould help ease the need for shares to finance AGNPFs future work. Should happen. Grant, partnership and ???. Issue the 65% AGN Neuro shares to current holders? It's a spec stock. Could happen
...GLTA...

Great possible dip and longer term thoughts. Math, from the blue truck driver has proven strong, IMO. About time for longs to get a 'breath' and then maybe staying through the news, Long. Got to play the full game/hands/all cards...
Some micro dose @ 4mins +. An actually good video overall about the current micro dose trends..

...GLTA...

..youtube.com/watch?v=eOGG_5FzlJ4

NUO could be buying up more current production, resources and mines like LLG or GBM or ?, to get their future share of this corner of the Graphite market. I hope, LOL.

Please folks...

So AGN Canada to include Neuro can buy 2 shares @ $.55.
US can buy Neuro only shares @$.73
AGNPF 2 shares including 65% of neuro @ $.40 but only what's available right now.
So, buy into the new plans or be diluted. Speculative investing in the only real medical DMT (microdose) use seems for stroke rehab, with an IPF future for Ifenprodil. That's the deal?
...GLTA...

Still holding some of those goog shares, wish all my investments turned out that well.
LOL. Agn is a spec, Nasdaq is a goal...GLTA...

The AGN CSX doesnt want my money or US regulations. So, 2 shares @ $.53 for US now and 1 'right' for $.18 and a warrant for $.38 later, ($.50) plus at the discount when/if AGN goes to $.73. A fair deal for both, IMO. Nasdaq is US...
Got to invest in what's happening right now or not. The past is a different hand / review, IMO.
I was mad once at some management fubars when they sold ONT to Goog 2-2010, 75 for 1.
Gotta to play to stay relevant? Die hard or hold/sell. IMO...
...GLTA...

Yes we are waiting semi-patiently and AGNPF owns 65% of AGNneuro.
...GLTA...

NMG is to sign deal with Mason / other graphite resourses, All sales have buyers,
GBM next? Highest quality/easy access.
Seems to me they want to compete with China for future EV battery market?

AGNPF holds 65% of AGNNeuro.
The bet of Ifenprodil use for COVID is history but the IPF/CC path remains valid, IMO.
If an investor held BTH from day one without any trading that was their decision to make and responsibility, IMO.
Most should not be down >50% and the future still holds promise, IMO.
That is also the risk taken with a speculative stock and the possible rewards. IMO.

Look at PFE/MDNA over a 5 year chart. They were certainly not a speculative investment and will Never have the chance of a spec gain like AGNN/AGNPF IF/when. JMHFO...

AGN is a speculative buy, IMO.
...GLTA...

https://ir.algernonpharmaceuticals.com/news-events/press-releases/detail/177/algernon-neuroscience-appoints-global-tbi-expert-and-former

Yea we all lost 17% so you could get a paltry18K shares and save $280 AFTER pumping Bullish $.07 + comments. So glad you're here. Brilliant...
...GLTA...

February 16, 2023, VANCOUVER, B.C. Green Battery Minerals Inc. (” Green” or the “Company”) (TSX-V: GEM, FSE: BK2P, WKN: A2QENP OTC: GBMIF) is pleased to announce assay results from the surface work conducted at Zone 6 last summer.

...GLTA...

https://greenbatteryminerals.com/green-battery-minerals-gem-acquires-additional-graphite-bearing-claims-to-extend-the-berkwood-graphite-project/

750M OS, 1.5M avg last 3 months / 2 year+, looks like most longs holding, IMO. PCT is a spec gamble, with fair possibilities, IMO.
...GLA...

you
"IMO, there remains ZERO legitimate rebuttals to ANY of the concerns I’ve raised regarding Algernon Pharmaceuticals Inc."
me
Sounds like a sell and move on evaluation of AGN's market and conditions in your opinion.

Wow, OK...
Sorry for trying to answer courteously with my comments and opinions of how I see the past and current facts...
Again...

...GLTA...

Financing the DMT Trial is from selling 37% of AGNNeuro shares. So Yes, I believe that is a fair deal for AGN shareholders.

COVID was scammed by Phiser/Fousi and even MDNA was pushed aside. All repurposed drugs from several companies were forced to do Trials while Phiser was given a pass and subsidized Trials/research. So inaccurate question IMO., but there are many articles on these subjects.

Ifenprodil did not fail it's CT and there were significant benefits proven including IL-6 for COVID patients and CC reduction / slowing rate of IPF in that 2nd Phase 2 CT for Ifenprodil. i.e. a Phase 2b CT for CC this summer/asap...
I would talk about Cancer But Cancer use for Ifenprodil is another repurposed direction still being applied for ODD/IND status at the FDA and a current CT is not being planned. Maybe later as with the CKD drug. So Yes.
...(I have discussed Cancer in private, confidentially, but I dislike malfeasant sour grapes, so that's over) ....!!

Accusing the AGN CEO of being a drunk is a TOS violation, IMHFO...

If you dont like the company;s format for repurposed drugs then sell the rest of any shares you may still have and move on. I plan to buy more.

Taking comments out of context, ie Shell, is unfair IMO.

You're Buddy...

...GLTA...

Well, thanks for making me look up the actual CT. New update Feb1, 2023 compared to the WAG from initial announcements in Sept 2022.
There appears to be an estimated Phase 1 DMT completion date (this PY) of May 2023 and study data in June 2023 now. Not EOY as stated earlier in videos. Maybe I misunderstood the earlier comments, but,,,
Seems things are moving right along at CHDR in the Netherlands. Recruiting.
So, Ifenprodil CC trials start this summer along with DMT Phase 2a.?..?.
63% AlgernonNeuro (DMT) and 100% Algernon Ifenprodil-CC plus CKD eventually is what we own.?....Sounds great... That's a Buy @ these lows, IMO. .. I've been waiting but I'll start to move some money tomorrow and do that asap ...
You're buddy,,,

...GLTA...

https://www.clinicaltrials.gov/ct2/show/NCT05559931?term=DMT&cntry=NL&draw=2&rank=1

BTH went from $.07 to $.30 and it was easy to recoup that investment. If one didn't then it was a personal decision.
AGN went from $.15 to $.35 so the same there. BA went from $37 to $450 and then back to $120. Same comment again. Bloz went from $.50 to $.3.50 and is now $.40>>>???<<<
No guarantees on anything in life. Gotta take personal responsibility for stuff, IMHFO...
There are some that put big money on the table here yet they accept their decisions and may still be around. Not kibitzing actions the company's made or about market realities or about THEIR investment into a speculative stock.
Maybe some should try and run a company themselves. Lawn mowing anyone???
Get greedy and pump / hold all shares too long or bash and complain about the I Wish/Want/Think in hindsight scenarios, look in the mirror.
I'm no genius either... Many are smarter...

...GLTA...